APC
CGEN icon

Aspire Private Capital’s Compugen CGEN Stock Holding History

Aspire Private Capital’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-335
Closed -$1K – 535
2019
Q1 		$1K Hold
335
– – ﹤0.01% 484
2018
Q4 		$1K Buy
+335
New +$1.06K ﹤0.01% 453

Other funds holding CGEN

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Aspire Private Capital's CGEN Position: Q2 2019 in Review

Aspire Private Capital sold out of Compugen (CGEN) in Q2 2019, closing a stake of 335 shares — an estimated $1K sold.

Aspire Private Capital first reported a position in CGEN in Q4 2018 and held it in 2 quarters. The position peaked at $1K in Q1 2019. 41 funds tracked by Wall St. Rank hold CGEN as of Q2 2019.

  • Aspire Private Capital reported no remaining Compugen position as of Q2 2019 after selling out during the quarter.
  • Aspire Private Capital sold 335 Compugen shares in Q2 2019, an estimated $1K.
  • Aspire Private Capital first reported a position in Compugen in Q4 2018 and held it in 2 quarters.
  • Aspire Private Capital's Compugen position peaked at $1K in Q1 2019.
  • 41 funds tracked by Wall St. Rank held Compugen as of Q2 2019.

Based on Aspire Private Capital's 13F filing for Q2 2019, filed 13 Aug 2019.